A Study of Ruxolitinib in Pancreatic Cancer Patients
Clinical trial NCT02119663 · TERMINATED
Trial details
- NCT number
- NCT02119663
- Sponsor
- Incyte Corporation
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-06-01
- Primary completion
- 2016-02-01
- Enrollment
- 86
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.